Shandong Binzhou Zhiyuan Biotechnology Co. Ltd succeed in CPHI India 2016

India is a developing country, developed the generics industry, has a title "world pharmacy" , it exported to more than and 100 countries in the world, India has become one of the major global generics production center, and to the drug manufacturing centre, Biotechnology Research Center and the center for clinical trials forward.

Shandong Binzhou Zhiyuan Biotechnology Co., seize the opportunity for development, expand marketing channels, to develop the European market at the same time, to enter the India market, November 2016 21-23 CPHi India for us to make new friends, find new opportunities to provide an excellent opportunity, and greet old friends, met new friends to further enhance our own the India CPHi exhibition. Our company mainly products exhibition hydroxypropyl betacyclodextrin, sulfobutyl ether beta cyclodextrin sodium access to users of all ages, our times of hydroxypropyl sulfobutyl ether cyclodextrin and he spoke highly of the quality of the products he times cyclodextrin sodium, very recognized technical advantages of our enterprise, reliable quality guarantee system, a high level of R & D declaration, expressed the desire of long-term cooperation!

Shandong Binzhou Zhiyuan Biotechnology Co. Ltd is professional manufacturer of pharmaceutical excipients cyclodextrin, cyclodextrin and cyclodextrin derivatives hydroxypropyl betacyclodextrin and sulfobutyl ether beta cyclodextrin sodium as medicinal materials have the following functions: solubilization and dissolution, to cover up the smell, anti oxygenation, sustained release, targeted drug delivery, liquid drug powder, increase the bioavailability.

Shandong Binzhou Zhiyuan Biotechnology Co. Ltd. has been entering the global market permits, products have been in the United States FDA registration, hydroxypropyl cyclodextrin approval number: Lu Yao Zhunzi F2015001, DMF record number 030168; Ding Ji - ether betacyclodextrin sodium accepting registration number: CXFS1500004 Lu, DMF number 030167, welcomed the consultation audit!